MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ismail, A.-S.A.
Right arrow Articles by Grem., J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ismail, A.-S.A.
Right arrow Articles by Grem., J. L.

Vol. 53, Issue 2, 252-261, February 1998

Modulation of Fluorouracil Cytotoxicity by Interferon-alpha and -gamma

A.-S.A. Ismail,1 C. J. Van Groeningen,2 A. Hardcastle, Q.-F. Ren, G. W. Aherne, F. Geoffroy, C. J. Allegra, and J. L. Grem.

National Cancer Institute-Navy Medical Oncology Branch (A.-S.A.I., C.J.V.G., Q.-F.R., F.G., C.J.A., J.L.G.), National Naval Medical Center, Bethesda, Maryland 20889, and CRC Centre for Cancer Therapeutics at The Institute of Cancer Research (A.H., G.W.A.), Belmont, Sutton, Surrey SM2 5NG, UK

Because interferons (IFN)-alpha and -gamma individually have increased fluorouracil (FUra) cytotoxicity in several in vitro models, we studied the effects of FUra combined with IFN-alpha  + gamma  in HT29 colon cancer cells. A 96-hr exposure to IFN-alpha (500 units/ml) plus IFN-gamma (10 units/ml) and a 72-hr exposure to 0.25-1 µM FUra (hr 24-96) inhibited cell growth and colony formation in an additive or more-than-additive fashion. When cells were exposed to IFN-alpha gamma  and FUra, free FdUMP levels became detectable, whereas [3H]FUra-RNA incorporation decreased. Exposure to IFN-alpha  + gamma , FUra, or the combination decreased dTTP pools to 58%, 43%, and 17% of control, respectively. A marked increase in the dATP to dTTP ratio was seen with FUra with or without IFN-alpha  + gamma . Thymidylate synthase catalytic activity was reduced to 28% and 24% of control with FUra with or without IFN-alpha  + gamma , suggesting that the enhanced dTTP depletion must be due to another mechanism. FUra-mediated thymidylate synthase inhibition was accompanied by a 124-fold increase in total deoxyuridylate immunoreactivity and a 31-fold increase in dUTP pools, but the addition of IFN-alpha  + gamma  attenuated the accumulation. Treatment with IFN-alpha  + gamma  and FUra individually interfered with nascent DNA chain elongation, whereas the three-drug combination produced the most striking effects. IFN-alpha  + gamma  plus FUra produced the greatest amount of single-strand breaks in nascent DNA and dramatically decreased net DNA synthesis. IFN-alpha  + gamma  with or without FUra produced double-strand breaks in parental DNA. These results suggest that dTTP depletion, dATP/dTTP imbalance, pronounced inhibition of DNA synthesis, and damage to nascent and parental DNA contribute to the enhanced cytotoxicity with the triple combination.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
S. Oie, M. Ono, H. Fukushima, F. Hosoi, H. Yano, Y. Maruyama, M. Kojiro, T. Terada, K. Hirano, M. Kuwano, et al.
Alteration of dihydropyrimidine dehydrogenase expression by IFN-{alpha} affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells
Mol. Cancer Ther., August 1, 2007; 6(8): 2310 - 2318.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Andersen, T. Heine, R. Sneve, I. Konig, H. E. Krokan, B. Epe, and H. Nilsen
Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts
Carcinogenesis, March 1, 2005; 26(3): 547 - 555.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. L. Grem, N. Harold, J. Shapiro, D.-Q. Bi, M. G. Quinn, S. Zentko, B. Keith, J. M. Hamilton, B. P. Monahan, S. Donavan, et al.
Phase I and Pharmacokinetic Trial of Weekly Oral Fluorouracil Given With Eniluracil and Low-Dose Leucovorin to Patients With Solid Tumors
J. Clin. Oncol., December 1, 2000; 18(23): 3952 - 3963.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. M. Tillman, I. Petak, and J. A. Houghton
A Fas-dependent Component in 5-Fluorouracil/Leucovorin-induced Cytotoxicity in Colon Carcinoma Cells
Clin. Cancer Res., February 1, 1999; 5(2): 425 - 430.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics